Sitagliptin
Sitagliptin is a DPP-4 inhibitor used for type 2 diabetes. It supports glucose control but does not replace nutrition, activity and monitoring plans.
Key points
- Kidney function affects sitagliptin exposure and treatment selection.
- Low blood glucose risk rises when it is combined with insulin or a sulfonylurea.
- Severe persistent abdominal pain, facial swelling or a blistering skin reaction needs urgent care.
Select a listed product and pack to order online. Suitability and supply depend on clinician and pharmacy checks, stock, destination rules and prescription requirements.
How it works
Sitagliptin blocks DPP-4, prolonging incretin activity so insulin release increases and glucagon decreases when glucose is elevated.
Important safety checks
Kidney function, pancreatitis history, heart-failure symptoms, pregnancy and other diabetes medicines require review. Report severe joint pain or a new tense blistering rash. Follow the diabetes sick-day and glucose-monitoring plan.
When to seek urgent care
Seek urgent help for severe persistent upper-abdominal pain with or without vomiting, facial or throat swelling, breathing difficulty, extensive blistering skin, severe confusion, loss of consciousness or a seizure from low blood glucose.
Further reading
Related articles

22 Sept 2026 ⋅ 6
Single-Ingredient vs Combination Diabetes Medicines
Learn how to read single-ingredient and fixed-dose combination diabetes medicines, including paired strengths, formulations and duplicate ingredients.
Read guide
